Intralytix (United States)
Intralytix, Inc. is a privately owned biotech venture incorporated in the State of Maryland on July 28, 1998. Intralytix specializes in bacteriophage based products used to control bacterial pathogens in environmental, agricultural, food processing, and medical settings. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Intralytix (United States), United States, covering academic research published from 2003 to 2023. Read More.
Open Access Percentage
75%
Total
Publications
60
Total Open
Publications
45
Total
Citations
3.6K
Open Access
Percentage
75%
Total
Publications
60
Total Open
Publications
45
Total
Citations
3.6K
Breakdown
Publisher Open
17%
Both
43%
Other Platform Open
15%
Closed
25%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 36%
13
Hybrid 42%
15
No Guarantees 22%
8
Other Platform Open
Domain 83%
29
Institution 23%
8
Public 14%
5
Other Internet 6%
2
Preprint 3%
1
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 28 |
Europe PMC | Domain | 23 |
Semantic Scholar | Public | 4 |
Vrije Universiteit Amsterdam - VU Research Portal | Institution | 3 |
U.S. Department of Energy Office of Scientific and Technical Information - OSTI OAI | Institution | 2 |
Le Centre pour la Communication Scientifique Directe - HAL - Inria | Institution | 2 |
Ghent University - Ghent University Academic Bibliography | Institution | 2 |
DOI | Other Internet | 2 |
University of Copenhagen - Research at the University of Copenhagen | Institution | 1 |
Spanish National Research Council (CSIC) - DIGITAL.CSIC | Institution | 1 |